Identification of transcriptomic determinants to predict the efficacy of anti-EGFR treatment of colorectal cancer patients.

被引：0
|
作者：
Chowdhury, Saikat [1 ]
Shen, John Paul Y. C. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期
关键词：
D O I：
10.1200/JCO.2021.39.3_suppl.130
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
130
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Optimizing Anti-EGFR Therapy in Colorectal Cancer
    Salazar, Ramon
    Ciardiello, Fortunato
    CLINICAL CANCER RESEARCH, 2015, 21 (24) : 5415 - 5416
  • [12] Anti-EGFR MoAb treatment in colorectal cancer: limitations, controversies, and contradictories
    Cheng, Lei
    Ren, Wei
    Xie, Li
    Li, Ming
    Liu, Jiang
    Hu, Jing
    Liu, Bao-Rui
    Qian, Xiao-Ping
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (01) : 1 - 13
  • [13] Panitumumab: A new anti-EGFR antibody for the treatment of advanced colorectal cancer
    Chu, Edward
    CLINICAL COLORECTAL CANCER, 2006, 6 (01) : 13 - 13
  • [14] Activation of Signal Pathways and the Resistance to Anti-EGFR Treatment in Colorectal Cancer
    Chen, Jiezhong
    Huang, Xu-Feng
    Katsifis, Andrew
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2010, 111 (05) : 1082 - 1086
  • [15] Anti-EGFR MoAb treatment in colorectal cancer: limitations, controversies, and contradictories
    Lei Cheng
    Wei Ren
    Li Xie
    Ming Li
    Jiang Liu
    Jing Hu
    Bao-Rui Liu
    Xiao-Ping Qian
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 1 - 13
  • [16] Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?
    Derangere, Valentin
    Fumet, Jean David
    Boidot, Romain
    Bengrine, Leila
    Limagne, Emeric
    Chevriaux, Angelique
    Vincent, Julie
    Ladoire, Sylvain
    Apetoh, Lionel
    Rebe, Cedric
    Ghiringhelli, Francois
    ONCOTARGET, 2016, 7 (08) : 9310 - 9322
  • [17] Beyond KRAS:Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer
    Alfonso De Stefano
    Chiara Carlomagno
    World Journal of Gastroenterology, 2014, (29) : 9732 - 9743
  • [18] Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer
    De Stefano, Alfonso
    Carlomagno, Chiara
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (29) : 9732 - 9743
  • [19] ANTI-EGFR ANTIBODY RECHALLENGE IN CHEMOREFRACTORY PATIENTS WITH METASTATIC COLORECTAL CANCER
    Kajitani, Tatsuhiro
    Makiyama, Akitaka
    Arita, Shuji
    Kumagai, Hozumi
    Oda, Hisanobu
    Shirakawa, Tsuyoshi
    Esaki, Taito
    ANNALS OF ONCOLOGY, 2014, 25
  • [20] Anti-EGFR (cetuximab) combined with irinotecan for treatment of elderly patients with metastatic colorectal cancer (mCRC)
    S. Abdelwahab
    A. Azmy
    H. Abdel-aziz
    H. Salim
    A. Mahmoud
    Journal of Cancer Research and Clinical Oncology, 2012, 138 : 1487 - 1492
12345